Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Caro-Sánchez Claudia HS"'
Autor:
Garcia-Ortega Dorian Yarih, Caro-Sánchez Claudia HS, Alvarez-Cano Alethia, Alvarez-Bojorquez Mario, Melgarejo-Estefan Emmanuel, Rodríguez-Ayala Ernesto
Publikováno v:
Rare Tumors, Vol 13 (2021)
Sarcomas are a heterogenous group of malignant tumors with origin or mesenchymal differentiation, they comprise 1–2% of all solid tumors. Retroperitoneum is the second most frequent site affected. Prognosis is worse compared to the limbs, with a 5y
Externí odkaz:
https://doaj.org/article/15a4608f23a84541a32600c62054646a
Autor:
Caro-Sánchez Claudia Hs, Alvarez-Cano Alethia, Garcia-Ortega Dorian Yarih, Melgarejo-Estefan Emmanuel, Alvarez-Bojorquez Mario, Rodríguez-Ayala Ernesto
Publikováno v:
Rare Tumors, Vol 13 (2021)
Rare Tumors
Rare Tumors
Sarcomas are a heterogenous group of malignant tumors with origin or mesenchymal differentiation, they comprise 1–2% of all solid tumors. Retroperitoneum is the second most frequent site affected. Prognosis is worse compared to the limbs, with a 5y
Autor:
Soldevilla-Gallardo I; Department of Nuclear Medicine, Instituto Nacional De Cancerología Mexico, Mexico., Medina-Ornelas SS; Department of Nuclear Medicine, Instituto Nacional De Cancerología Mexico, Mexico., Villarreal-Garza C; Department of Oncology, Instituto Nacional De Cancerología Mexico, Mexico., Bargalló-Rocha E; Department of Breast Tumors, Instituto Nacional De Cancerología Mexico, Mexico., Caro-Sánchez CH; Department of Patologhy, Instituto Nacional De Cancerología Mexico, Mexico., Hernández-Ramírez R; Department of Nuclear Medicine, Instituto Nacional De Cancerología Mexico, Mexico., Estrada-Lobato E; Human Health Department International Atomic Energy Agency (IAEA).
Publikováno v:
American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2018 Oct 20; Vol. 8 (5), pp. 341-350. Date of Electronic Publication: 2018 Oct 20 (Print Publication: 2018).
Autor:
Soldevilla-Gallardo I; Nuclear Medicine Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Villaseñor-Navarro Y; Imaging Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Medina-Ornelas SS; Nuclear Medicine Department, Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: smedinao@incan.edu.mx., Villarreal-Garza C; Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Bargalló-Rocha E; Breast Tumors Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Caro-Sánchez CH; Patologhy Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Gallardo-Alvarado LN; Breast Tumors Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Hernández-Ramírez R; Nuclear Medicine Department, Instituto Nacional de Cancerología, Mexico City, Mexico., Arela-Quispe LM; Nuclear Medicine Department, Instituto Nacional de Cancerología, Mexico City, Mexico., García-Pérez FO; Nuclear Medicine Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Publikováno v:
Cancer treatment and research communications [Cancer Treat Res Commun] 2018; Vol. 16, pp. 24-31. Date of Electronic Publication: 2018 May 14.